Parametrica Management Ltd purchased a new stake in USANA Health Sciences, Inc. (NYSE:USNA) in the 4th quarter, HoldingsChannel reports. The institutional investor purchased 5,451 shares of the company’s stock, valued at approximately $404,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. California State Teachers Retirement System increased its position in USANA Health Sciences by 0.5% in the 2nd quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock valued at $1,319,000 after acquiring an additional 100 shares during the period. Legal & General Group Plc increased its position in shares of USANA Health Sciences by 7.6% during the second quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after buying an additional 284 shares during the period. JPMorgan Chase & Co. increased its position in shares of USANA Health Sciences by 2.1% during the second quarter. JPMorgan Chase & Co. now owns 16,385 shares of the company’s stock worth $1,050,000 after buying an additional 341 shares during the period. New York State Common Retirement Fund increased its position in shares of USANA Health Sciences by 1.2% during the second quarter. New York State Common Retirement Fund now owns 32,534 shares of the company’s stock worth $2,085,000 after buying an additional 370 shares during the period. Finally, AHL Partners LLP increased its position in shares of USANA Health Sciences by 0.5% during the second quarter. AHL Partners LLP now owns 89,919 shares of the company’s stock worth $5,764,000 after buying an additional 424 shares during the period. Hedge funds and other institutional investors own 44.35% of the company’s stock.

Several equities research analysts have recently weighed in on USNA shares. BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th. Sidoti cut shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research report on Wednesday, January 24th. Finally, Pivotal Research increased their price objective on shares of USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th.

In related news, Director Myron W. Wentz sold 164,916 shares of the stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $66.40, for a total transaction of $10,950,422.40. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Myron W. Wentz sold 1,985 shares of the stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $66.01, for a total transaction of $131,029.85. Following the transaction, the director now directly owns 12,011,418 shares in the company, valued at $792,873,702.18. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 386,120 shares of company stock valued at $25,580,462. 53.20% of the stock is currently owned by corporate insiders.

Shares of USANA Health Sciences, Inc. (USNA) opened at $73.60 on Friday. USANA Health Sciences, Inc. has a 12-month low of $52.55 and a 12-month high of $76.80. The firm has a market cap of $1,798.24, a price-to-earnings ratio of 19.83 and a beta of 0.99.

COPYRIGHT VIOLATION NOTICE: This story was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://theolympiareport.com/2018/02/03/5451-shares-in-usana-health-sciences-inc-usna-acquired-by-parametrica-management-ltd.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.